Results 131 to 140 of about 65,591 (261)

Molecular subtype concordance and metastatic patterns in muscle‐invasive bladder cancer

The Journal of Pathology: Clinical Research, Volume 12, Issue 3, May 2026.
Abstract Molecular subtypes are potential prognostic and predictive tools in muscle‐invasive bladder cancer (MIBC). However, subtype concordance between primary tumors and metastases, as well as subtype‐specific differences in metastatic patterns, remain poorly characterized.
Csilla Olah, Dániel Juhász, Melinda Váradi, Henning Reis, Mulham Al‐Nader, Osama Mahmoud, Barbara T. Grünwald, Viktor Grünwald, Boris Hadaschik, Péter Nyirády, Tibor Szarvas   +10 more
wiley   +1 more source

SURVIVAL IN PATIENTS WITH HISTOLOGIC VARIANTS OF UROTHELIAL TYPE BLADDER CANCER

Jurnal Urologi Indonesia
Objective: This study aims to determine the life expectancy of patients with histologic variants in urothelial type bladder cancer and the highest or lowest mortality rate in Hasan Sadikin Academic Medical Centre.
Richard Hartanto, Sawkar Vijay Pramod
doaj   +1 more source

Primary ureteral undifferentiated sarcoma with rapid intra‐abdominal recurrence in a dog

Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 3‐year‐old female spayed puli was presented for trembling, lethargy, panting and anorexia. An abdominal computed tomography (CT) scan revealed a mass arising from the right ureter. Peritoneal effusion was detected and confirmed to be uroabdomen. A right ureteronephrectomy was performed.
Emily A. Pope, Kate Sarkan, Megan E. Schreeg, Janis Lapsley, Hunter J. Piegols   +4 more
wiley   +1 more source

Proximal ureteral fibroepithelial polyp with secondary renal atrophy in a dog (Canis lupus familiaris)

Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 12‐year‐old, male intact, Papillon dog was presented following trauma from a motor vehicle accident. On arrival, the dog was laterally recumbent with neurological dysfunction (modified Glasgow coma scale 12) and multiple injuries, including right hip luxation and suspected haemorrhage.
Charles T. Talbot, Xiaobo Wang, Ji‐Hang Yin   +2 more
wiley   +1 more source

The Regulation and Function of Hippo/YAP Pathway in Cancer

The FASEB Journal, Volume 40, Issue 7, 15 April 2026.
Hippo/YAP pathway signaling plays critical roles in the progression of multiple cancer types. This review summarizes current knowledge of Hippo/YAP pathway regulation and function in cancer. We discuss the core components of the Hippo/YAP pathway; its crosstalk with other signaling pathways; regulation by non‐coding RNAs; roles of YAP signaling in ...
Chinmoy Ghosh, Ruchi Kakar, Seline Torkamboor, Yue Sun   +3 more
wiley   +1 more source

Pathogenic Neurofibromatosis type 1 gene variants in tumors of non‐NF1 patients and role of R1276

FEBS Open Bio, Volume 16, Issue 4, Page 803-813, April 2026.
Somatic variants of the neurofibromatosis type 1 (NF1) gene occur across neoplasms without clinical manifestation of the disease NF1. We identified emerging somatic pathogenic NF1 variants and hotspots, for example, at the arginine finger 1276. Those missense variants provide fundamental information about neurofibromin's role in cancer.
Mareike Selig, Swanhild Lohse, Sara Elahi, Nils Hartmann, Stefanie Deckert, Shutian Si, Alexander Desuki, Anja Harder   +7 more
wiley   +1 more source

Analysis of CacyBP/SIP, ERK1/2, and p38 Expression in Low‐ and High‐Grade Papillary Urothelial Carcinoma

Cancer Medicine
Background Papillary urothelial carcinoma (transitional cell carcinoma) is one of the most common malignant tumors of the urinary tract. Urothelial carcinomas are classified into muscle‐invasive and non‐muscle‐invasive types.
Natalia Domian, Grzegorz Młynarczyk, Irena Kasacka   +2 more
doaj   +1 more source

Perinephric and Ovarian Metastasis from Advanced Urothelial Carcinoma Bladder: Case Report of a Rare Dismal Disease

Asian Pacific Journal of Cancer Care
Background: Metastatic urothelial carcinoma bladder at the time of diagnosis is a rare entity with lymph nodes, bones, lung and liver as common metastatic sites. Sometimes metastasis can be seen in various atypical sites.
Poorva Vias, Ashish Saklani, Suman Singh, Anantika Thakur, Era Sankhyan   +4 more
doaj   +1 more source

Addition of immune checkpoint inhibitors to intravesical BCG for high‐risk BCG‐naïve non‐muscle invasive bladder cancer: Systematic review and meta‐analysis

BJUI Compass, Volume 7, Issue 4, April 2026.
Abstract Objective The objective of this study is to assess the efficacy, safety and change in quality of life associated with ICI‐BCG (I + M) compared to BCG (I + M) in patients with BCG‐naïve HR‐NMIBC. Material and Methods A systematic search was run on PubMed, Embase and CENTRAL from inception to 29 October 2025. Phase 3 randomized controlled trials
Renil S. Titus, Carlos Riveros, Eusebio Luna Velasquez, David‐Dan Nguyen, Suran Somawardana, Amar Singh, Dharam Kaushik, Guru Sonpavde, Alexandre Zlotta, Girish Kulkarni, Srikala S. Sridhar, Christopher J. D. Wallis, Raj Satkunasivam   +12 more
wiley   +1 more source

Influence of Gut Microbiota on Response to Immune Check Point Inhibitors in MASLD Patients With HCC: Unraveling the Connection

Cancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Immune checkpoint inhibitors (ICIs) have emerged as a promising treatment for various cancers, including advanced hepatocellular carcinoma (HCC). However, a significant proportion of patients with HCC, particularly those with metabolic dysfunction‐associated liver disease (MASLD), exhibit resistance to ICI therapy.
Mazen Elsheikh, Mohamad Ali Ibrahim, Sherry Fares, Megha Bhongade, Karim Adhem, Ximena I. Ramirez‐Morales, Ahmed O. Kaseb, Joseph Petrosino, Manal M. Hassan, Prasun K. Jalal   +9 more
wiley   +1 more source